Published in Womens Health Issues on February 20, 2006
Denial of abortion because of provider gestational age limits in the United States. Am J Public Health (2013) 1.29
Secondary measures of access to abortion services in the United States, 2011 and 2012: gestational age limits, cost, and harassment. Womens Health Issues (2014) 0.92
Legal barriers to second-trimester abortion provision and public health consequences. Am J Public Health (2009) 0.84
Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000. Ann Intern Med (2005) 3.55
Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis. Ann Intern Med (2011) 3.52
Effect of managed care insurance on the use of preventive care for specific ethnic groups in the United States. Med Care (2002) 2.34
Variation in access to health care for different racial/ethnic groups by the racial/ethnic composition of an individual's county of residence. Med Care (2004) 2.25
Measuring patient preferences for colorectal cancer screening using a choice-format survey. Value Health (2007) 1.86
Estimates of pregnancies averted through California's family planning waiver program in 2002. Perspect Sex Reprod Health (2006) 1.74
Using the coronary artery calcium score to guide statin therapy: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes (2014) 1.65
Impact of increased access to emergency contraceptive pills: a randomized controlled trial. Obstet Gynecol (2006) 1.59
The association of race, socioeconomic status, and health insurance status with the prevalence of overweight among children and adolescents. Am J Public Health (2003) 1.53
You say "regret" and I say "relief": a need to break the polemic about abortion. Contraception (2008) 1.40
Rates and predictors of colorectal cancer screening. Prev Chronic Dis (2006) 1.31
Denial of abortion because of provider gestational age limits in the United States. Am J Public Health (2013) 1.29
The effect of area HMO market share on cancer screening. Health Serv Res (2004) 1.29
How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated-choice survey. Health Econ (2009) 1.27
At what cost? Payment for abortion care by U.S. women. Womens Health Issues (2013) 1.24
Contraceptive use and risk of unintended pregnancy in California. Contraception (2004) 1.23
How the new medicare drug benefit could affect vulnerable populations. Health Aff (Millwood) (2006) 1.21
The role of emergency contraception. Am J Obstet Gynecol (2004) 1.19
Understanding why women seek abortions in the US. BMC Womens Health (2013) 1.15
How does cost matter in health-care discrete-choice experiments? Health Econ (2011) 1.15
An experiment on simplifying conjoint analysis designs for measuring preferences. Health Econ (2003) 1.14
Coverage policy development for personalized medicine: private payer perspectives on developing policy for the 21-gene assay. J Oncol Pract (2010) 1.14
Predictors of delay in each step leading to an abortion. Contraception (2008) 1.13
Health technology assessment and private payers' coverage of personalized medicine. J Oncol Pract (2011) 1.10
Women's emotions one week after receiving or being denied an abortion in the United States. Perspect Sex Reprod Health (2013) 1.08
Eligibility criteria in private and public coverage policies for BRCA genetic testing and genetic counseling. Genet Med (2011) 1.07
Women's out-of-pocket expenditures and dispensing patterns for oral contraceptive pills between 1996 and 2006. Contraception (2010) 1.06
Moving beyond the typologies of managed care: the example of health plan predictors of screening mammography. Health Serv Res (2004) 1.03
Incidence of emergency department visits and complications after abortion. Obstet Gynecol (2015) 1.02
A health services research agenda for cellular, molecular and genomic technologies in cancer care. Public Health Genomics (2009) 1.01
Does patient cost sharing matter? Its impact on recommended versus controversial cancer screening services. Am J Manag Care (2004) 0.97
Personalized medicine and oncology practice guidelines: a case study of contemporary biomarkers in colorectal cancer. J Natl Compr Canc Netw (2011) 0.95
Biotechnology and Medicare's new technology policy: lessons from three case studies. Health Aff (Millwood) (2006) 0.94
Resistance and vulnerability to stigmatization in abortion work. Soc Sci Med (2011) 0.94
Risk of violence from the man involved in the pregnancy after receiving or being denied an abortion. BMC Med (2014) 0.93
Association of regional variation in primary care physicians' colorectal cancer screening recommendations with individual use of colorectal cancer screening. Prev Chronic Dis (2007) 0.92
Women's perspectives on ultrasound viewing in the abortion care context. Womens Health Issues (2012) 0.92
Social sources of women's emotional difficulty after abortion: lessons from women's abortion narratives. Perspect Sex Reprod Health (2011) 0.91
Willing and able? Provision of medication for abortion by future internists. Womens Health Issues (2005) 0.91
Is the prevalence of gatekeeping in a community associated with individual trust in medical care? Med Care (2003) 0.90
Tradeoffs of using administrative claims and medical records to identify the use of personalized medicine for patients with breast cancer. Med Care (2011) 0.90
Drug withdrawals in the United States: a systematic review of the evidence and analysis of trends. Curr Drug Saf (2007) 0.88
Pharmacy access to emergency contraception in California. Perspect Sex Reprod Health (2006) 0.88
Variation in screening mammography and Papanicolaou smear by primary care physician specialty and gatekeeper plan (United States). Cancer Causes Control (2004) 0.88
Medicare formulary coverage for top-selling biologics. Nat Biotechnol (2009) 0.87
Looking back at 10 years of trastuzumab therapy: what is the role of HER2 testing? A systematic review of health economic analyses. Per Med (2009) 0.87
Adolescent and young women's experience with the vaginal ring and oral contraceptive pills. J Pediatr Adolesc Gynecol (2007) 0.87
Patient viewing of the ultrasound image prior to abortion. Contraception (2013) 0.87
Normalizing the exceptional: incorporating the "abortion pill" into mainstream medicine. Soc Sci Med (2003) 0.87
Influence of patient preferences on the cost-effectiveness of screening for lynch syndrome. J Oncol Pract (2012) 0.87
Colorectal cancer screening differential costs for younger versus older Americans. Am J Prev Med (2006) 0.86
Cervical cancer screening continues to limit provision of contraception. Contraception (2005) 0.86
Attitudes and decision making among women seeking abortions at one U.S. clinic. Perspect Sex Reprod Health (2012) 0.86
Development and validation of a reproductive autonomy scale. Stud Fam Plann (2014) 0.86
Effect of abortion protesters on women's emotional response to abortion. Contraception (2012) 0.85
Capacity building for assessing new technologies: approaches to examining personalized medicine in practice. Per Med (2010) 0.85
Economic evaluation of targeted cancer interventions: critical review and recommendations. Genet Med (2011) 0.85
Legal barriers to second-trimester abortion provision and public health consequences. Am J Public Health (2009) 0.84
Abortion patients' perceptions of abortion regulation. Womens Health Issues (2010) 0.83
Provider practice models for and costs of delivering medication abortion -- evidence from 11 US abortion care settings. Contraception (2006) 0.83
Angiotensin receptor blockers on the formularies of Medicare drug plans. J Gen Intern Med (2007) 0.83
Health technology assessment and private payers's coverage of personalized medicine. Am J Manag Care (2011) 0.83
Multiple determinants of the abortion care experience: from the patient's perspective. Am J Med Qual (2013) 0.81
Genomic testing and therapies for breast cancer in clinical practice. Am J Manag Care (2011) 0.81
Genomic testing and therapies for breast cancer in clinical practice. J Oncol Pract (2011) 0.81
Disparities in abortion rates: a public health approach. Am J Public Health (2013) 0.81
Changes in abortion provider practices in response to the Partial-Birth Abortion Ban Act of 2003. Contraception (2009) 0.80
Gene expression profile testing for breast cancer and the use of chemotherapy, serious adverse effects, and costs of care. Breast Cancer Res Treat (2011) 0.80
Private Companies Providing Health Care Price Data: Who Are They and What Information do They Provide? J Manag Care Med (2014) 0.79
How women anticipate coping after an abortion. Contraception (2011) 0.79
Viagra and contraceptives. Health Aff (Millwood) (2003) 0.79
User characteristics and out-of-pocket expenditures for progestin-only versus combined oral contraceptives. Contraception (2012) 0.79
Bringing evidence to the debate on abortion coverage in health reform legislation: findings from a national survey in the United States. Contraception (2010) 0.79
Effects of simplifying choice tasks on estimates of taste heterogeneity in stated-choice surveys. Soc Sci Med (2009) 0.78
Influence of patient preferences on the cost-effectiveness of screening for Lynch syndrome. Am J Manag Care (2012) 0.78
Beyond political claims: women's interest in and emotional response to viewing their ultrasound image in abortion care. Perspect Sex Reprod Health (2014) 0.77
Measuring managed care and its environment using national surveys: a review and assessment. Med Care Res Rev (2006) 0.77
Relationship between ultrasound viewing and proceeding to abortion. Obstet Gynecol (2014) 0.77
Rethinking the mantra that abortion should be "safe, legal, and rare". J Womens Hist (2010) 0.76
Analyzing the impacts of abortion clinic structures and processes: a qualitative analysis of women's negative experience of abortion clinics. Contraception (2011) 0.76
Evaluating the potential impact of pharmacogenomics on ADRs. J Manag Care Pharm (2003) 0.75
Approaches to male hypogonadism in primary care. Nurse Pract (2017) 0.75
Letter to the editor: response to "What women want from abortion counseling in the United States: a qualitative study of abortion patients in 2008". Soc Work Health Care (2012) 0.75
Addressing the silence in the noise: how abortion support talklines meet some women's needs for non-political discussion of their experiences. Women Health (2012) 0.75
Willingness to recommend a health plan: who is dissatisfied and what don't they like? Am J Manag Care (2004) 0.75
Insured women and payment for elective abortion. Womens Health Issues (2008) 0.75
The Komen-Planned parenthood controversy: bringing the politics of breast cancer advocacy to the forefront. Womens Health Issues (2012) 0.75
Reducing Unnecessary Head Computed Tomography in Mild Traumatic Brain Injury. Adv Emerg Nurs J (2017) 0.75
A qualitative study of insurers' coverage for mifepristone-induced abortion. Manag Care Interface (2005) 0.75